Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX   US23283K1051

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/16/2015 01/20/2015 01/21/2015 01/22/2015 01/23/2015 Date
0.4766(c) 0.4671(c) 0.479(c) 0.4798(c) 0.4789(c) Last
1 308 520 907 387 831 986 1 311 966 796 497 Volume
+7.34% -1.99% +2.55% +0.17% -0.19% Change
More quotes
Company
Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose-derived stem and regenerative cells to treat cardiovascular disease and repair soft tissue defects.It automates the extraction and preparation of clinical grade adipose-derived stem and regenerative cells using device,... 
More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 9,24 M
EBIT 2014 -32,5 M
Net income 2014 -36,5 M
Debt 2014 -
Yield 2014 -
Sales 2015 16,3 M
EBIT 2015 -26,9 M
Net income 2015 -29,5 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 4,79x
Capi. / Sales 2015 2,72x
Capitalization 44,3 M
More Financials
Latest news on CYTORI THERAPEUTICS INC
01/23 CYTORI THERAPEUTICS : Posts 'STAR' Trial Information on Website
01/21 CYTORI THERAPEUTICS : FDA OKs Cytori U.S. Pivotal Scleroderma Trial
01/20 CYTORI THERAPEUTICS : and Leading Expert Discuss Importance of ‘STAR&rsquo..
01/15 CYTORI THERAPEUTICS : FDA OKs Cytori U.S. Pivotal Scleroderma Trial
01/12 CYTORI THERAPEUTICS : Regulation FD Disclosure, Financial Statements and Exhibit..
01/12 CYTORI THERAPEUTICS : FDA Approves Cytori U.S. Pivotal Scleroderma Trial
01/08 CYTORI THERAPEUTICS : Submission of Matters to a Vote of Security Holders (form ..
01/01 CYTORI THERAPEUTICS : and BARDA Amend Contract Option to Accelerate the Advancem..
More news
Sector news Medical Equipment, Supplies & Distribution - NEC
01/24 ESSILOR INTL : among world’s most sustainable companies for third year run..
01/23 IDEXX LABORATORIES : to Release 2014 Fourth Quarter and Full-Year Financial Resu..
01/23 COVIDIEN : Supports Retreat and Refresh Stroke Camp for Stroke Survivors and Car..
Plus d'actualités du secteur Medical Equipment, Supplies & Distribution - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF